EP Patent

EP3559121A4 — NEW PROCESS FOR THE PRODUCTION OF INDIGOTINE DISULFONATE SODIUM (INDIGO-CARMINE)

Assigned to Provepharm Life Solutions SA · Expires 2020-11-04 · 6y expired

What this patent protects

Patent listed against indigotindisulfonate-sodium.

Drugs covered by this patent

indigotindisulfonate-sodium (INDIGOTINDISULFONATE SODIUM)

Patent Metadata

Patent number: EP3559121A4
Jurisdiction: EP
Classification: —
Expires: 2020-11-04
Drug substance claim: No
Drug product claim: No
Assignee: Provepharm Life Solutions SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.